Xeris Pharmaceuticals | XERS - Debt

Stock Price
7.85
Daily Change
-0.04 -0.51%
Monthly
42.99%
Yearly
212.75%
Q3 Forecast
7.78

Xeris Pharmaceuticals reported $257.22M in Debt for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 334.69M
Cash and Equivalent USD 59.28M
Cost of Sales USD 11.9M
Current Assets USD 185.58M
Current Liabilities USD 95.17M
Debt USD 257.22M
EBIT USD 5.43M
EBITDA USD 8.59M
Employees 377
EPS Earnings Per Share USD -0.01
Equity Capital and Reserves USD -19.3M
Gross Profit on Sales USD 59.64M
Interest Expense on Debt USD 7.36M
Interest Income USD 948K
Loan Capital USD 218.63M
Market Capitalization USD 1.1B
Net Income USD -1.93M
Operating Expenses USD 67.06M
Operating Profit USD 4.48M
Ordinary Share Capital USD 161.22M
Pre-Tax Profit USD -1.93M
Sales Revenues USD 71.54M
Selling and Administration Expenses USD 44.39M
Stock USD 67.28M
Trade Creditors USD 9.46M
Trade Debtors USD 53.05M

Debt Change Date
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Celltrion KRW 2.22T 24.87B Mar/2025
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Tilray USD 351.72M 15.26M Nov/2024
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025